Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3132 of 6351
-
Neck stretching may beat placebo for pinched nerve pain
Symptom relief Recruiting nowCervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment. Second-line surgical treatments appear to…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
App aims to stop depression before it starts in chinese american teens
Prevention Recruiting nowThe goal of this clinical trial is to test if a culturally sensitive mobile health application (Relax, Reflect, Empower-RRE) is feasible and effective in promoting psychological wellbeing and reducing depressive symptoms among Chinese American adolescents (CAA). We will conduct a…
Sponsor: Northeastern University • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Could a stretchy tape give overhead athletes stronger, less tired shoulders?
Symptom relief CompletedMaintaining shoulder stability requires good neuromuscular control. Imbalances in shoulder internal and external rotator strength may increase the risk of shoulder injuries in overhead athletes, and the compromised fatigue resistance of the external rotators may worsen this imbal…
Sponsor: National Yang Ming Chiao Tung University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New narcolepsy drug shows promise in reducing sudden sleep attacks and muscle collapse
Symptom relief CompletedThe purpose of this research study is to assess the safety and efficacy of ALKS 2680 compared to placebo, including whether participants taking ALKS 2680 experience a greater decrease in sleepiness and a decrease in cataplexy ("sudden loss of muscle control"), compared to partici…
Phase 2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New balloon treatment for clogged arteries under study
Disease control Recruiting nowThe IMAGINATION trial is an investigator-initiated, prospective, single-center study of symptomatic patients with a native chronic total occlusion (CTO) undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB). Po…
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for rare gut disease? small study tests biologic drug
Disease control CompletedBehçet's syndrome is a systemic vasculitis. Gastrointestinal involvement in Behçet's syndrome complicated by myelodysplastic syndrome represents a rare and severe subtype for which no standardized treatment guidelines currently exist, posing significant challenges in clinical pra…
Phase 2 • Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Period power: study seeks to tame blood sugar swings in type 1 diabetes
Knowledge-focused Recruiting nowThe objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic varia…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gentle touch or core strength? trial tests best combo for back pain
Symptom relief CompletedThis randomized controlled trial aims to compare the effectiveness of Bowen Therapy combined with McGill stabilization exercises versus Bowen Therapy alone in individuals with chronic nonspecific low back pain. The study will evaluate changes in pain intensity, lumbar range of mo…
Sponsor: Sehat Medical Complex • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New nasal spray could offer quick migraine relief for those on preventives
Symptom relief Recruiting nowZavegepant (Zavzpret) is approved for the acute treatment of migraine with or without aura in the US. The purpose of this study is to investigate the effectiveness and tolerability of zavegepant for the acute treatment of migraine attacks amongst participants who are using calcit…
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 26, 2026 15:09 UTC
-
Diabetes drug may help fatty liver – new study investigates
Knowledge-focused CompletedMetabolic dysfunction-associated steatotic liver disease (MASLD), a condition where fat builds up in the liver, is common in patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may help improve liver health, but their effects on liver stiffness and fa…
Sponsor: Josip Juraj Strossmayer University of Osijek • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New glasses could slow Kids' worsening eyesight
Disease control OngoingThe goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essil…
Sponsor: Essilor International • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Blood test may predict immunotherapy success in advanced cancers
Knowledge-focused Recruiting nowThis is an observational clinical trial, aiming to investigate whether the ctDNA dynamics could predict early response to ICIs in patients with advanced-stage cancer. Moreover, conventional tumor markers PD-L1, TMB and MSI are to be investigated for their combined prognostic valu…
Sponsor: Gene Solutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New app aims to help hispanic kids breathe easier
Disease control CompletedThis is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Biofeedback breakthrough: new study targets depression subtypes
Knowledge-focused Recruiting nowAlthough treatments for depression are effective for many people, not everyone responds to treatment. This lack of treatment response could be due, in part, to the presence of multiple underlying causes of people's depression. This study aims to identify subtypes of depression, b…
Phase 2 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Lung cancer combo trial halted early: what happened?
Disease control Stopped earlyThe purpose of this study was to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered to participants with non-small cell lung cancer (NSCLC) following resection and adjuvant chemotherapy.
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Coffee break for cancer survivors: could your morning cup fight liver fat?
Disease control Recruiting nowThis is research study is assessing the effects of 6-g daily use of freeze-dried instant coffee on liver fat and fibrosis and the gut microbiome and metabolome in patients who have completed routine treatment (including surgery, chemotherapy and radiotherapy) for stage I-III colo…
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Vitamin B6 shows promise for diabetes blood vessel health
Disease control CompletedPatients with type 2 diabetes have an increased risk of developing vascular complications. Microvascular dysfunction might be caused by the increased production of methylglyoxal under hyperglycaemic conditions. Methylglyoxal is a by-product of glycolysis and forms advanced glycat…
Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
When to start walking rehab after spinal injury? new study seeks answer.
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate if a specific type of additional walking therapy, called body weight supported treadmill training (BWSTT) affects walking ability following a traumatic spinal cord injury. Specifically, the study will look at whether starting BWSTT, which …
Sponsor: Milap Sandhu • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New Gene-Targeting drug could change how we treat high blood pressure
Disease control OngoingThis Phase 1 study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ADX-850 in participants with hypertension.
Phase 1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New program boosts HIV prevention in young men
Prevention CompletedThe proposed study will involve adolescent (17-24 years old) men who have sex with men (described as YMSM hereafter) who meet eligibility criteria to participate. Prospective study candidates will receive a copy of the IRB-approved informed consent forms and, if they choose to pa…
Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC